Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. May 14, 2023; 29(18): 2836-2849
Published online May 14, 2023. doi: 10.3748/wjg.v29.i18.2836
Figure 3
Figure 3 The immunohistory results. A: A de novo colorectal cancer (CRC) pathological section stained with E-cad and vimentin (VIM); B: A carcinoma in adenoma CRC pathological section stained with E-cad and VIM. VIM: Vimentin.